“Bio plasma” doesn’t refer to a single thing. Depending on the context, it can mean the liquid component of your blood (biological plasma), a homeopathic supplement sold under the brand name “Bioplasma,” or the use of ionized gas in medical treatments like skin tightening and wound healing. Here’s what each one involves and why it matters.
Blood Plasma: The Liquid Part of Your Blood
The most fundamental meaning of bio plasma is blood plasma, the pale-yellow fluid that carries your red blood cells, white blood cells, and platelets throughout your body. It makes up about 55% of your total blood volume, and roughly 92% of plasma itself is water. Proteins account for another 7%, including antibodies that fight infection, clotting factors that stop bleeding, and albumin that helps regulate fluid balance. The remaining 1% is a mix of hormones, vitamins, salts, and enzymes.
Plasma does several critical jobs at once. It transports nutrients and waste products between organs, distributes heat evenly through your body, and maintains blood pressure by keeping the right amount of fluid inside your blood vessels. Doctors measure plasma osmolality (essentially how concentrated the dissolved particles are) as a window into hydration and metabolic health. A normal reading falls between 275 and 295 mmol/kg. Values above that range can signal dehydration, uncontrolled blood sugar, or kidney problems. Values below it may point to overhydration, low sodium, or an underactive thyroid.
Plasma vs. Serum
You’ll sometimes see “plasma” and “serum” used as though they’re interchangeable, but they’re collected differently and have different compositions. Plasma is obtained by adding an anticoagulant to a blood sample so the blood never clots. Serum is the liquid left over after blood is allowed to clot naturally. The key difference is that plasma still contains fibrinogen, the protein that forms the mesh-like structure of a blood clot. Serum does not, because fibrinogen gets consumed during clotting. Which one a lab uses depends on what’s being tested.
Bioplasma: The Homeopathic Cell Salt Supplement
If you searched “bio plasma” after seeing it on a store shelf, you probably encountered Bioplasma, a homeopathic product that combines 12 mineral compounds known as cell salts. The idea, rooted in 19th-century biochemic medicine, is that the body needs trace minerals to function properly and that supplying them in highly diluted form can support overall health.
The 12 ingredients in a standard Bioplasma tablet are calcium fluoride, calcium phosphate, calcium sulfate, iron phosphate, potassium chloride, potassium phosphate, potassium sulfate, magnesium phosphate, sodium chloride, sodium phosphate, sodium sulfate, and silica. Each is diluted to either 3X or 6X potency, meaning the original mineral has been diluted by a factor of 1,000 or 1,000,000, respectively. These dilutions follow standards set by the Homeopathic Pharmacopoeia of the United States (HPUS).
Proponents claim Bioplasma helps with fatigue, stress, and general mineral balance. It’s important to understand that at these dilution levels, very little of the original mineral remains in each dose. Mainstream medical organizations generally do not recognize homeopathic preparations as effective treatments, and large-scale clinical evidence supporting cell salt therapy is limited. The product is sold as a dietary supplement and is not evaluated by the FDA for treating or preventing any disease.
Cold Atmospheric Plasma in Medicine
A newer and increasingly visible use of “bio plasma” refers to cold atmospheric plasma (CAP), an ionized gas used in medical and cosmetic procedures. Unlike the superheated plasma inside stars, CAP operates close to room temperature, making it safe enough to apply directly to living tissue.
CAP works by generating reactive oxygen and nitrogen species, molecules that are chemically active enough to kill bacteria, promote wound healing, or damage abnormal cells. In dermatology, this technology shows up as plasma fibroblast therapy. A pen-like device creates a tiny arc of ionized gas that delivers a controlled burst of energy to the skin’s surface. This creates microinjuries, small enough that the outer skin layer acts as a natural dressing. In response, fibroblast cells in the deeper skin layer activate to repair and regenerate tissue. The result is tighter, smoother skin with relatively quick recovery compared to more invasive procedures.
The FDA cleared one cold plasma device, the MIRARI Cold Plasma System, in late 2024 for certain uses. In the cosmetic space, plasma pens are widely available, though the quality and safety of devices vary significantly. Treatments should be performed by trained professionals, since the device creates real thermal energy on the skin and improper use can cause scarring or pigmentation changes.
Cold Plasma and Cancer Research
One of the more promising areas of cold plasma research involves cancer treatment. In laboratory studies, CAP selectively damages tumor cells while leaving healthy cells relatively unharmed. This selectivity appears to stem from key differences between cancer cells and normal cells. Tumor cell membranes contain less cholesterol, making them more permeable to the reactive molecules that plasma generates. Cancer cells also have more water-channel proteins on their surface, which allows damaging molecules to enter more easily. On top of that, CAP seems to overwhelm the antioxidant defenses that cancer cells rely on to survive.
Inside the cell, the reactive molecules produced by plasma cause DNA strand breaks, trigger stress responses in energy-producing structures, and activate self-destruct pathways. CAP also appears to provoke a type of cell death that alerts the immune system, potentially training the body to recognize and attack remaining tumor cells. In the surrounding tissue, plasma disrupts the structural scaffolding that tumors use to spread, inhibiting cancer cell migration and invasion.
Despite these encouraging lab results, cold plasma therapy for cancer is not yet a standard clinical treatment. The only reported human applications so far have been in palliative care for advanced head and neck cancers and infected tumor wounds. The technology remains in the laboratory research stage for oncology, though the pace of investigation has accelerated in recent years.